01 26ASTRAZENECA
01 28425934
02 410300065
03 210300065*PED
04 28425934*PED
05 14RE46276
06 2RE46276*PED
01 14Y
02 12Blank
01 16Y
02 10Blank
01 142024-10-30
02 22025-04-30
03 22030-04-17
04 22030-10-17
05 42036-01-27
06 22036-07-27
Patent Expiration Date : 2024-10-30
US Patent Number : RE46276
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22433
Patent Use Code : U-1936
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-10-30
Patent Expiration Date : 2024-10-30
US Patent Number : RE46276
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22433
Patent Use Code : U-1935
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-10-30
Patent Expiration Date : 2024-10-30
US Patent Number : RE46276
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22433
Patent Use Code : U-1935
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-10-30
Patent Expiration Date : 2024-10-30
US Patent Number : RE46276
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22433
Patent Use Code : U-1938
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-10-30
Patent Expiration Date : 2024-10-30
US Patent Number : RE46276
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22433
Patent Use Code : U-1936
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-10-30
Patent Expiration Date : 2036-01-27
US Patent Number : 10300065
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code : U-2541
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-01-27
Patent Expiration Date : 2036-01-27
US Patent Number : 10300065
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code : U-2541
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-01-27
Patent Expiration Date : 2036-01-27
US Patent Number : 10300065
Drug Substance Claim :
Drug Product Claim :
Application Number : 22433
Patent Use Code : U-2542
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-01-27
Patent Expiration Date : 2024-10-30
US Patent Number : RE46276
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22433
Patent Use Code : U-1937
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-10-30
Patent Expiration Date : 2024-10-30
US Patent Number : RE46276
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22433
Patent Use Code : U-1937
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-10-30
LOOKING FOR A SUPPLIER?
